Akebia Therapeutics to Host Analyst and Investor Day on June 27, 2017
June 20 2017 - 7:00AM
Business Wire
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical
company focused on delivering innovative therapies to patients with
kidney disease through the biology of hypoxia-inducible factor
(HIF), today announced that it will host an Analyst and Investor
Day on Tuesday, June 27, 2017. The event is scheduled to take place
from 8:00-11:00 AM Eastern Time in New York City.
The agenda will include a review of the Company's HIF programs
as well as presentations by the following guest speakers:
- Geoffrey A. Block, M.D., Director of
Research, Denver Nephrology
- Cormac Taylor B.Sc., Ph.D., Professor
of Cellular Physiology, University College Dublin, School of
Medicine
A live audio webcast of the event will be available on the
Company's website at http://ir.akebia.com/events.cfm. To ensure a
timely connection, users should register at least 15 minutes prior
to the scheduled start. An archived replay will be available for 90
days.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a biopharmaceutical company
headquartered in Cambridge, Massachusetts, focused on
delivering innovative therapies to patients with kidney disease
through hypoxia-inducible factor biology. Akebia's lead product
candidate, vadadustat, is an oral, investigational therapy in
development for the treatment of anemia related to chronic kidney
disease in both non-dialysis and dialysis patients. Akebia's global
Phase 3 program for vadadustat, which includes the PRO2TECT studies
for non-dialysis patients with anemia secondary to chronic kidney
disease and the INNO2VATE studies for dialysis-dependent patients,
is currently ongoing. For more information, please visit our
website at www.akebia.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170620005296/en/
Akebia:Theresa McNeely, 617-844-6113SVP, Corporate
Communicationsand Investor Relationstmcneely@akebia.com
Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Apr 2023 to Apr 2024